本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cytek BioSciences

3.44
+0.10002.99%
盘后3.42-0.0200-0.58%18:30 EDT
成交量:156.62万
成交额:535.95万
市值:4.36亿
市盈率:-38.76
高:3.47
开:3.34
低:3.33
收:3.34
数据加载中...
2024/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/22

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/09

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities